Whenever I get confused I got back to this
.. and whenever I get confused, I go back to this π
Whenever I get confused I got back to this
.. and whenever I get confused, I go back to this π
Under some conditions, and I am open to this, this may permit crosstalk with other death machineries, but to the best of my judgement the evidence that it is simply upstream of apoptosis, cathepsin-dependent death, or other canonical programs remains unconvincing
But I think we may be moving toward a more nuanced view. βFerroptosisβ could be an umbrella term encompassing distinct organelle membranes, each controlled by distinct enzymatic and non-enzymatic protective systems.
In that setting, ferroptosis does not look to me like apoptosis or lysosomal cell death by another route.
That is why I have generally felt that placing ferroptosis among the necrotic forms of cell death was a useful approximation.
On mechanism, in many genetic screens, we have never seen a convincing contribution from apoptosis, cathepsins, or similar pathways, at least in clean systems where GPX4 inhibition is the initiating event.
There is also a "marketing" side to this discussion, it is easier to build attention, legitimacy, and funding around a βcell death pathwayβ than around a ROS-driven cellular event.
That does not make the biology any less important, but I do think the framing has partly been shaped by that dynamic.
Is it a distinct cell death pathway? I think that is a fair description, though Iβm happy to leave the formal taxonomy to nomenclature-organizing colleagues in the cell death field.
π° good Monday morning exercise π°
My two cents on this - ferroptosis is best understood as a terminal process that begins once lipid oxidative damage exceeds the cellβs buffering and repair capacity.
Does it lead to cell death? Clearly yes.
would you also call them drug tolerant? I find sometime hard to follow on these nomenclatures and what they really mean -
Very grateful to receive the Deutscher Krebspreis 2026 (Experimental Cancer Research) together with Marcus Conrad. This recognition reflects the incredible efforts of our teams and collaborators over the years
@uni-wuerzburg.de
Pleased to share our recent work out today in @natmetabolism.nature.com. This study addresses a longstanding mystery - NRF2-driven cancers increase cysteine acquisition (via xCT) by ~5x - so where does all that cysteine go?
Uproar in Germany over law requiring men get military approval for long stays abroad
www.theguardian.com/world/2026/a...
If you are a postdoc or grad students that wants to be considered for a talk at the GRS then get your abstract in! (Deadline 5th April).
If a week by the Mediterranean discussing the latest research Bridging Redox Chemistry to Biology, Aging and Disease sounds like a welcome escape, then this Gordon Research Conference could be for you! www.grc.org/thiol-based-...
Excited to co-chair the 2026 Gordon Research Seminar (GRS) on Thiol-Based Redox Regulation & Signaling with Taylor Covington, a meeting for early career researchers in redox research
π Castelldefels (Barcelona), Spain βοΈ
π
July 11β12, 2026
#Redox #Thiols #EarlyCareerResearchers
More details β
Very grateful to receive the Deutscher Krebspreis 2026 (Experimental Cancer Research) together with Marcus Conrad. This recognition reflects the incredible efforts of our teams and collaborators over the years
@uni-wuerzburg.de
Isn't this like normal?
Happy to share the final version of the study where we describe a central role for vitaminB2 in regulating membrane redox state - some new cool experiments were added since the preprint was posted - pls check this out
thttps://www.nature.com/articles/s41556-025-01856-x
Interested in investigating dietary and metabolic regulation of immune responses? We have a PostDoc and a PhD position available in the lab.
karriereamukb.de/jobs/postdoc...
This is figure 5, which shows that the riboflavin antimetabolite roseoflavin disrupts FSP1 activity.
A study in Nature Cell Biology identifies riboflavin, vitamin B2, as a regulator of FSP1 stability that modulates phospholipid peroxidation and ferroptosis sensitivity in cancer cells. underscoring the therapeutic potential of targeting riboflavin metabolism. go.nature.com/4blD8Gi #medsky π§ͺ
Interesting and systematic evaluation that consolidates many observations the field has already been converging on: GPX4 dependency appears to be overestimated in vivo. Suggesting that exploiting high-PUFA states in specific cancer entities is unlikely to benefit from single-target GPX4 inhibition.
Interesting and systematic evaluation that consolidates many observations the field has already been converging on: GPX4 dependency appears to be overestimated in vivo. Suggesting that exploiting high-PUFA states in specific cancer entities is unlikely to benefit from single-target GPX4 inhibition.
Hei Derek!
Thanks a lot π
#Vitamin B2 is converted into molecules which protect cells from oxidative damage. The downside: It also protects #cancer cells. Scientists at the Rudolf Virchow Centre at #JMU discovered that. πΈ Natalie Fahmer
β‘οΈ www.uni-wuerzburg.de/en/news-and-...
also see the study from @olzmannlab.bsky.social who independently report on the importance of vitaminB2 on
ferroptosis
www.nature.com/articles/s41...
Happy to share the final version of the study where we describe a central role for vitaminB2 in regulating membrane redox state - some new cool experiments were added since the preprint was posted - pls check this out
thttps://www.nature.com/articles/s41556-025-01856-x
π§ What if metabolic defects are not just a consequence of inflammatory disease - but actively contribute to it?
Inflammation and metabolism are deeply intertwined, but the molecular links remain unclear.
Our new paper in Cell Death & Differentiation uncovers one. π§΅π
nature.com/articles/s41...
It's shaping up to be an amazing line up at the Gordon Cell Death meeting! Register now! www.grc.org/cell-death-c...